27Jan 2020


  • M. Pharmacy, Dept. Of Pharmaceutics, Government Collage of Pharmacy, Aurangabad- 431001
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Pharmacovigilance play an important role in the healthcare system through monitoring and interaction of drugs and there effects in the human body. In this article includes good manufacturing practices (GCP) and (ICH) guidelines for pharmaceuticals for human use are examined as an important aspects in the transformation of clinical trial to the objective of pharmacovigilance In pharmaceutical production India becomes third largest country in the world. Nowadays in India pharmacovigilance gives awareness about adverse drug reactions (ADR) and this review gives information about implementation for solving current problems. This article summarized objective and methodology used in pharmacovigilance with their overview of existing in India and their challenges and future expectance.

  1. Mandal, S. C.; Mandal, M. Evolution of Pharmacovigilance Programme : Present Status in India Evolution of Pharmacovigilance Programme : Present Status in India. 2017, No. June.
  2. Kumar, S.; Baldi, A. Pharmacovigilance in India: Perspectives and Prospects. Journal of Drug Delivery and Therapeutics2013, 3 (4), 237?246.
  3. Naman M Singh, K.; Kanase, H. R. Pharmacovigilance Programme of India: The Beginning, Current Status and Recent Progress. Advances in Pharmacoepidemiology and Drug Safety2017, 06 (04), 4?6.
  4. Suke, S. G.; Kosta, P.; Negi, H. Role of Pharmacovigilance in India: An Overview. Online Journal of Public Health Informatics2015, 7 (2).
  5. Pharmacovigilance of bio therapeutic Medicines : Identifying Global Case Studies.
  6. Wanmali, V. V; Brahmane, R. I.; Gupta, R. Review Article PHARMACOVIGILANCE.
  7. Laporte, J. The Case-Population Strategy in Pharmacovigilance. 2013, No. June.
  8. Campbell, J. E.; Gossell-Williams, M.; Lee, M. G. A Review of Pharmacovigilance. West Indian Medical Journal2014, 63 (7), 771?774
  9. Tyagi, P. Pharmacovigilance - A Review. 2017, 5 (1), 12?17.
  10. Patel, A.; Giles, D.; Thomas, V.; Pm, G.; Patel, R. Pharmacovigilance: A Review. International Journal of Pharmaceutical & Biological Archives2011, 2 (6), 1569?1574.
  11. Rajgopal, J. K. M.; Shilpi, K.; Ak, S. PHARMACOVIGILANCE : A REVIEW ARTICLE. 2016, 4 (4), 5?6.
  12. Ghewari, P. S.; Salunkhe, S. S.; Bhatia, N. M.; Killedar, S. G. Strategies and Current Scenario of Pharamcovigilance in India. 2014, 1 (3).
  13. Wal, P.; Mehra, R.; Rizvi, S.; Vajpayee, R. Review Article PHARMACOVIGILANCE : NEED FOR INDIAN PHARMA INDUSTRY. 2015, 6 (11), 740?743.
  14. Singh, S.; Prakash, J.; Goyal, N.; Tomar, R.; Chaudhary, A. Review on Pharmacovigilance. 2015, 4 (06), 266?275.
  15. Liu, X. Identifying Adverse Drug Events from Patient Social Media: A Case Study for Diabetes. 1?12.

[Sangita Fulchand Pawar and Vikram Limbaji Musale (2020); PHARMACOVIGILANCE: A REVIEW Int. J. of Adv. Res. 8 (1). 235-243] (ISSN 2320-5407). www.journalijar.com

Vikram Limbaji Musale
m pharmacy, gov.collage of pharmacy, Aurangabad


Article DOI: 10.21474/IJAR01/10289       DOI URL: http://dx.doi.org/10.21474/IJAR01/10289

Share this article